Hemogenyx Pharmaceuticals (HEMO.L): CAR-T cell therapy update
06 Oct 2020
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare Conditions
HemoGenyx Pharmaceuticals Plc (HEMO:LON) | 1.6 0 (-1.8%) | Mkt Cap: 22.0m
- Published:
06 Oct 2020 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
2
Hemogenyx Pharmaceuticals (HEMO.L): CAR-T cell therapy update